Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Natural Health Alternatives

This article was originally published in The Tan Sheet

Executive Summary

Natural Health Alternatives: Expects purchase of Global Health Alternatives to be completed in July. Pompano Beach, Fla.-based NHT will acquire Global in exchange for 5.8 mil. shares of common stock on the consummation of the agreement and additional shares are "issuable" after the acquisition based on future earnings of Global. Based on a closing price of 7/8 per share on June 27, the value of the stock exchanged at closing is roughly $5.1 mil. Global markets and distributes natural health care products through drug and health food stores and directly to consumers. Following the purchase, Global will operate as a division of NHT. Brian Wolfson, current chairman of Global, will become chairman and chief financial officer of NHT. The acquisition will bring NHT into natural health products marketing for the first time ("The Tan Sheet" Feb. 10, p. 23)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087246

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel